Aslam Anis, PhD
Dr. Anis, National Director of the CIHR Canadian HIV Trials Network (CTN), is a respected health economist and sought-after speaker on the topic of economic evaluation and resource allocation in health care systems. Dr. Anis is also a Professor in the School of Population and Public Health (SPPH) at the University of British Columbia (UBC) and the Director of the Centre for Health Evaluation and Outcomes Sciences (CHEOS), a large multidisciplinary health outcomes research organization that often partners with the CTN. Dr. Anis’s primary areas of expertise include the cost-effectiveness of treatments for HIV/AIDS and other health care interventions. At both CHEOS and the CTN, Dr. Anis leads active research programs in pharmacoeconomics.
Dr. Anis’s research activities in the area of HIV/AIDS have been extensive. In the 1990s, Dr. Anis was among the first scholars worldwide to demonstrate the cost-effectiveness of anti-retroviral therapy (ART) and his work helped shape economic policies governing access to this critical treatment for persons living with HIV/AIDS. He has since published widely in the peer-reviewed literature on quality of life and health resource use and costs among HIV/AIDS patients treated and not treated with ART. Since his recruitment in 1995 to Providence Health Care (PHC), home to the CTN, Dr. Anis has fostered a network of world-class scientists in health economics and health services research in HIV/AIDS, driving numerous influential programs to inform health policy. In his leadership roles at the CTN, Dr. Anis has championed economic evaluation as a fundamental parallel component to medical research, recognizing the practical constraints on the public health care system and the need for objective decision-making tools.
Dr. Anis works closely with the research collaboration to investigate the socioeconomic aspects of the treatment and management of substance abuse, the North American Opiate Medication Initiative (NAOMI), which continues to inform health policies worldwide. From 2006 to 2009, Dr. Anis served as a member of the Canadian Institutes of Health Research HIV/AIDS Research Advisory Committee, whose mandate is to make recommendations to the government regarding research priorities for HIV/AIDS. From 2006 to 2007, Dr. Anis served on the Public Health Agency of Canada and CIHR Special Planning Committee to review the Federal Initiative on HIV/AIDS in Canada. In 2011, Dr. Anis was inducted as a Fellow of the Canadian Academy of Health Sciences.